Insiders KalVista Pharmaceuticals, Inc.

Equities

KALV

US4834971032

Market Closed - Nasdaq Other stock markets 21:00:00 10/05/2024 BST			5-day change	1st Jan Change
12.08 ^USD	-0.08%		-0.41%	-1.39%

04-22	Kalvista Pharmaceuticals, Inc. Appoints William C. Fairey to the Board of Directors	CI
04-15	Certain Common Stock of KalVista Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 15-APR-2024.	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kalvista Pharmaceuticals, Inc. Appoints William C. Fairey to the Board of Directors	04-22	CI
KalVista Pharmaceuticals Names Benjamin Palleiko as CEO	03-07	MT
KalVista Pharmaceuticals, Inc. Announces Board Changes	03-07	CI
KalVista Pharmaceuticals, Inc. Announces Chief Executive Officer Changes	03-07	CI
Kalvista Pharmaceuticals Insider Sold Shares Worth $613,205, According to a Recent SEC Filing	02-16	MT
Kalvista Pharmaceuticals Insider Sold Shares Worth $598,661, According to a Recent SEC Filing	02-16	MT
Kalvista Pharmaceuticals Insider Sold Shares Worth $422,827, According to a Recent SEC Filing	02-16	MT
Kalvista Pharmaceuticals Insider Sold Shares Worth $295,514, According to a Recent SEC Filing	01-12	MT
Kalvista Pharmaceuticals Insider Sold Shares Worth $360,453, According to a Recent SEC Filing	12-28	MT
KalVista Pharmaceuticals, Inc. Appoints Nicole Sweeny as Chief Commercial Officer	25/07/23	CI
Kalvista Pharmaceuticals Announces Benjamin L. Palleiko Promoted to President	05/01/23	CI
KalVista Pharmaceuticals Appoints Brian J.G. Pereira Chairman to Succeed Martin Edwards	17/10/22	MT
KalVista Pharmaceuticals, Inc. Announces Management Changes	17/10/22	CI
KalVista Pharmaceuticals, Inc. Announces Board Changes	27/05/22	CI
Insider Sell: Kalvista Pharmaceuticals	03/11/21	MT
Insider Sell: Kalvista Pharmaceuticals	04/10/21	MT
Insider Trends: Insider Sales Continue 90-Day Trend at KalVista Pharmaceuticals	05/08/21	MT
Insider Trends: Insider 90-Day Selling Trend Extended at KalVista Pharmaceuticals	05/08/21	MT
Insider Trends: 90-Day Insider Selling Trend Continued at KalVista Pharmaceuticals	02/07/21	MT
Insider Trends: Insider Extends 90-Day Selling Trend at KalVista Pharmaceuticals	12/06/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders KalVista Pharmaceuticals, Inc.

Equities

KALV

US4834971032

Insiders

Filters